Cellcolabs

No Coupons Found

It seems we don’t have any coupons for this category. Try searching for something else.

Receive Clinical Grade Stem Cells Based on 25 years of Leading Research

Cellcolabs Clinical is conducting clinical trials in the Bahamas using Mesenchymal Stem Cells (MSCs). Our MSCs are produced in Sweden and based on a production protocol developed at the world renowned Karolinska Institute.

 

Continuing the Research from Karolinska Institutet

Mesenchymal stem cells (MSCs) are a type of multipotent stem cell with anti-inflammatory, immunomodulatory and regenerative characteristics. They have been intensively researched over the past decades, and currently, there are hundreds of clinical trials with MSCs for a broad spectrum of conditions.

 

The MSCs used in these trials are produced by Cellcolabs AB at their facility in Stockholm, Sweden. The production process has been optimised through 25 years of academic research, and the cells are quality controlled according to the guidelines of the International Society for Cell and Gene Therapy. The manufacturing is approved by the Swedish Medical Products Agency and certified under GMP (Good Manufacturing Practice) standards. The clinical trials have received approval by local authorities.

 

Cellcolabs’ MSCs are derived from the bone marrow of healthy donors aged 18-30. These cells are likely more potent than cells derived from trial participants themselves. Using donated cells also means that trial participants do not need to endure cell extraction as part of the trial. 

 

Clinical trials

  • Prevention of Cardiovascular Disease
  • Musculoskeletal Injuries
  • Aging Frailty
  • Osteoarthritis
Bone-marrow derived mesenchymal stem cells
  • High-quality stem cells sourced from bone marrow of healthy donors.
  • Produced in Cellcolabs’ production facility in Sweden.
Safety profile
  • Analysis of 15+ years of MSC research indicates a strong safety profile.
  • Cell production according to GMP (Good Manufacturing Practice).
Widely researched
  • Based on over 20 years of academic research at Karolinska Institute.
  • Over hundreds of clinical trials globally on MSCs.